x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

36:02

DOACs and reversal agents for patients experiencing...

touchPODCAST ·

2023/08/10

touchEXPERT OPINIONS for touchCARDIOLOGY Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes. The experts: Prof. Hanne Christensen, University of Copenhagen, Denmark Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany Dr Truman Milling, The University of Texas at Austin, TX, USA This touchPODCAST is for HCPs

en

36:01

DOACs and reversal agents for patients experiencing...

touchPODCAST ·

2023/08/10

touchEXPERT OPINIONS for touchNEUROLOGY Leading experts share their insights on the impact of intracerebral haemorrhage (ICH) in patients receiving direct oral anticoagulants (DOACs), DOAC-ICH reversal agents and optimizing treatment outcomes. The experts: Prof. Hanne Christensen, University of Copenhagen, Denmark Prof. Thorsten Steiner, The Clinical Centre in Frankfurt Höchst, Frankfurt, Germany Dr Truman Milling, The University of Texas at Austin, TX, USA This touchPODCAST is for HCPs only. This

en

15:08

Key considerations in the management of irAEs with...

touchPODCAST ·

2023/08/09

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the case-based implementation of immune checkpoint inhibitors in endometrial cancer through shared decision making. The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline

en

12:10

Importance of shared decision making in the...

touchPODCAST ·

2023/08/09

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland Pathologist: Dr Tjalling Bosse, Leiden, Netherlands This touchPODCAST is for HCPs only. This activity is

en

14:31

Improving outcomes with ICIs in advanced or recurrent...

touchPODCAST ·

2023/08/09

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss improving outcomes with immune checkpoint inhibitors in advanced or recurrent endometrial cancer. The multidisciplinary team: Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is

en

35:07

Optimizing outcomes of JAK inhibition in...

touchPODCAST ·

2023/07/31

touchIN CONVERSATION for touchHAEMATOLOGY Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis. They respond to questions submitted by the HCP audience and provide expert insights on: The key considerations when selecting a first-line JAK inhibitor How to best manage side effects

en

35:06

Optimizing outcomes of JAK inhibition in...

touchPODCAST ·

2023/07/31

touchIN CONVERSATION for touchONCOLOGY Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis. They respond to questions submitted by the HCP audience and provide expert insights on: The key considerations when selecting a first-line JAK inhibitor How to best manage side effects

en

35:20

Preventing HPV-associated cancer by maximizing...

touchPODCAST ·

2023/07/31

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. The experts: Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa, Prof. Eduardo Franco OC, McGill University, Montreal, Canada, Prof. Daniel Kelly OBE, European Cancer Organisation,

en

35:21

Preventing HPV-associated cancer by maximizing...

touchPODCAST ·

2023/07/31

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. The experts: Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa, Prof. Eduardo Franco OC, McGill University, Montreal, Canada, Prof. Daniel Kelly OBE, European Cancer

en

36:26

Fulfilling the potential of HER2-targeting in...

touchPODCAST ·

2023/07/26

touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer. The experts Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK; Dr Andrea Cercek - Memorial Sloan Kettering Cancer Center, New York, NY, USA; Dr Elena Elez - Vall d'Hebron University

en

33:15

Migraine prevention in the real world: Exploring the...

touchPODCAST ·

2023/07/20

touchCLINICAL PERSPECTIVES for touchNEUROLOGY - Module 1 & 2 Module 1 Listen first to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options. The expert Professor Simona Sacco - University of L’Aquila, Italy Module 2 Listen next to a patient advocate providing her insights on the burden of migraine for patients and then to a clinical expert as he shares his perspectives on how

en

55:59

Advancing the management of adult solid tumours in...

touchPODCAST ·

2023/07/18

touchEXPERT OPINIONS for touchENDOCRINOLOGY Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration. The experts: Part 1 (00:00) Dr Stephen Graves, University of Iowa, Iowa City, IA, USA Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA Part 2

en

55:59

Advancing the management of adult solid tumours in...

touchPODCAST ·

2023/07/18

touchEXPERT OPINIONS for touchONCOLOGY Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration. The experts: Part 1 (00:00) Dr Stephen Graves, University of Iowa, Iowa City, IA, USA Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA Part 2

en

33:15

Current and future considerations for the use of...

touchPODCAST ·

2023/07/10

Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives. The expert Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchONCOLOGY

en

33:16

Current and future considerations for the use of...

touchPODCAST ·

2023/07/10

Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives. The expert Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchRESPIRATORY

en

38:20

Shaping ART around individual needs: Maximizing...

touchPODCAST ·

2023/06/29

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES Listen to a panel of experts discuss the importance of optimizing antiretroviral therapy through an individualized approach to care and shared decision making. The experts Prof Jens Lundgren, University of Copenhagen, Hvidovre, Denmark Prof Marta Boffito, Chelsea and Westminster Hospital and Imperial College London, UK Ms Angelina Namiba, 4M Network, UK This touchPODCAST is for HCPs only. This activity is funded by an independent medical

en

50:15

Latest developments in neuromyelitis optica spectrum...

touchPODCAST ·

2023/06/22

touchSATELLITE SYMPOSIUM for touchOPHTHALMOLOGY Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers. Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA). The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed

en

50:15

Latest developments in neuromyelitis optica spectrum...

touchPODCAST ·

2023/06/22

touchSATELLITE SYMPOSIUM for touchNEUROLOGY Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers. Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA). The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed by

en

39:32

Key considerations for treatment selection and...

touchPODCAST ·

2023/06/21

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM. The experts: Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical

en

39:32

Key considerations for treatment selection and...

touchPODCAST ·

2023/06/21

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM. The experts: Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter